These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 37547286)

  • 1. Therapeutic inhibition of miR-155 attenuates liver fibrosis via STAT3 signaling.
    Bala S; Zhuang Y; Nagesh PT; Catalano D; Zivny A; Wang Y; Xie J; Gao G; Szabo G
    Mol Ther Nucleic Acids; 2023 Sep; 33():413-427. PubMed ID: 37547286
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MicroRNA-98 Inhibits Hepatic Stellate Cell Activation and Attenuates Liver Fibrosis by Regulating HLF Expression.
    Wang Q; Wei S; Zhou H; Li L; Zhou S; Shi C; Shi Y; Qiu J; Lu L
    Front Cell Dev Biol; 2020; 8():513. PubMed ID: 32637414
    [TBL] [Abstract][Full Text] [Related]  

  • 3. miR-488-5p mitigates hepatic stellate cell activation and hepatic fibrosis via suppressing TET3 expression.
    Qiu J; Wu S; Wang P; Zhou Y; Wang Z; Sun Y; Jiang C
    Hepatol Int; 2023 Apr; 17(2):463-475. PubMed ID: 36001230
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hic-5 deficiency attenuates the activation of hepatic stellate cells and liver fibrosis through upregulation of Smad7 in mice.
    Lei XF; Fu W; Kim-Kaneyama JR; Omoto T; Miyazaki T; Li B; Miyazaki A
    J Hepatol; 2016 Jan; 64(1):110-7. PubMed ID: 26334580
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Physalin D attenuates hepatic stellate cell activation and liver fibrosis by blocking TGF-β/Smad and YAP signaling.
    Xiang D; Zou J; Zhu X; Chen X; Luo J; Kong L; Zhang H
    Phytomedicine; 2020 Nov; 78():153294. PubMed ID: 32771890
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exogenous Therapeutics of Microrna-29a Attenuates Development of Hepatic Fibrosis in Cholestatic Animal Model through Regulation of Phosphoinositide 3-Kinase p85 Alpha.
    Yang YL; Wang FS; Lin HY; Huang YH
    Int J Mol Sci; 2020 May; 21(10):. PubMed ID: 32455716
    [TBL] [Abstract][Full Text] [Related]  

  • 7. miR-455-3p Alleviates Hepatic Stellate Cell Activation and Liver Fibrosis by Suppressing HSF1 Expression.
    Wei S; Wang Q; Zhou H; Qiu J; Li C; Shi C; Zhou S; Liu R; Lu L
    Mol Ther Nucleic Acids; 2019 Jun; 16():758-769. PubMed ID: 31150929
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Kinin B1 receptor blockade attenuates hepatic fibrosis and portal hypertension in chronic liver diseases in mice.
    Rampa DR; Feng H; Allur-Subramaniyan S; Shim K; Pekcec A; Lee D; Doods H; Wu D
    J Transl Med; 2022 Dec; 20(1):590. PubMed ID: 36514072
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MicroRNA-497 induced by Clonorchis sinensis enhances the TGF-β/Smad signaling pathway to promote hepatic fibrosis by targeting Smad7.
    Zhou QY; Yang HM; Liu JX; Xu N; Li J; Shen LP; Zhang YZ; Koda S; Zhang BB; Yu Q; Chen JX; Zheng KY; Yan C
    Parasit Vectors; 2021 Sep; 14(1):472. PubMed ID: 34521449
    [TBL] [Abstract][Full Text] [Related]  

  • 10. miR-345-5p curbs hepatic stellate cell activation and liver fibrosis progression by suppressing hypoxia-inducible factor-1alpha expression.
    Wang P; Fang Y; Qiu J; Zhou Y; Wang Z; Jiang C
    Toxicol Lett; 2022 Nov; 370():42-52. PubMed ID: 36126797
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Liuweiwuling tablets attenuate BDL-induced hepatic fibrosis via modulation of TGF-β/Smad and NF-κB signaling pathways.
    Liu H; Dong F; Li G; Niu M; Zhang C; Han Y; He L; Yin P; Wang B; Sang X; Li R; Wang J; Bai Z; Xiao X
    J Ethnopharmacol; 2018 Jan; 210():232-241. PubMed ID: 28864168
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Knockout of microRNA-21 reduces biliary hyperplasia and liver fibrosis in cholestatic bile duct ligated mice.
    Kennedy LL; Meng F; Venter JK; Zhou T; Karstens WA; Hargrove LA; Wu N; Kyritsi K; Greene J; Invernizzi P; Bernuzzi F; Glaser SS; Francis HL; Alpini G
    Lab Invest; 2016 Dec; 96(12):1256-1267. PubMed ID: 27775690
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bile duct ligation-induced biliary hyperplasia, hepatic injury, and fibrosis are reduced in mast cell-deficient Kit
    Hargrove L; Kennedy L; Demieville J; Jones H; Meng F; DeMorrow S; Karstens W; Madeka T; Greene J; Francis H
    Hepatology; 2017 Jun; 65(6):1991-2004. PubMed ID: 28120369
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mesenchymal stem cells improve liver fibrosis and protect hepatocytes by promoting microRNA-148a-5p-mediated inhibition of Notch signaling pathway.
    Zhou Q; Rong C; Gu T; Li H; Wu L; Zhuansun X; Zhao X; Xiao Z; Kuang Y; Xu S; Wang S
    Stem Cell Res Ther; 2022 Jul; 13(1):354. PubMed ID: 35883205
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reticulon 4B (Nogo-B) is a novel regulator of hepatic fibrosis.
    Zhang D; Utsumi T; Huang HC; Gao L; Sangwung P; Chung C; Shibao K; Okamoto K; Yamaguchi K; Groszmann RJ; Jozsef L; Hao Z; Sessa WC; Iwakiri Y
    Hepatology; 2011 Apr; 53(4):1306-15. PubMed ID: 21480333
    [TBL] [Abstract][Full Text] [Related]  

  • 16. EW-7197 inhibits hepatic, renal, and pulmonary fibrosis by blocking TGF-β/Smad and ROS signaling.
    Park SA; Kim MJ; Park SY; Kim JS; Lee SJ; Woo HA; Kim DK; Nam JS; Sheen YY
    Cell Mol Life Sci; 2015 May; 72(10):2023-39. PubMed ID: 25487606
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of Cyclic Adenosine Monophosphate (cAMP)-response Element-binding Protein (CREB)-binding Protein (CBP)/β-Catenin Reduces Liver Fibrosis in Mice.
    Osawa Y; Oboki K; Imamura J; Kojika E; Hayashi Y; Hishima T; Saibara T; Shibasaki F; Kohara M; Kimura K
    EBioMedicine; 2015 Nov; 2(11):1751-8. PubMed ID: 26870800
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of TGF-β signaling in differentiation of mesothelial cells to vitamin A-poor hepatic stellate cells in liver fibrosis.
    Li Y; Lua I; French SW; Asahina K
    Am J Physiol Gastrointest Liver Physiol; 2016 Feb; 310(4):G262-72. PubMed ID: 26702136
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Conditional loss of heparin-binding EGF-like growth factor results in enhanced liver fibrosis after bile duct ligation in mice.
    Takemura T; Yoshida Y; Kiso S; Kizu T; Furuta K; Ezaki H; Hamano M; Egawa M; Chatani N; Kamada Y; Imai Y; Higashiyama S; Iwamoto R; Mekada E; Takehara T
    Biochem Biophys Res Commun; 2013 Jul; 437(2):185-91. PubMed ID: 23743191
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synergistic anti-liver fibrosis actions of total astragalus saponins and glycyrrhizic acid via TGF-β1/Smads signaling pathway modulation.
    Zhou Y; Tong X; Ren S; Wang X; Chen J; Mu Y; Sun M; Chen G; Zhang H; Liu P
    J Ethnopharmacol; 2016 Aug; 190():83-90. PubMed ID: 27282665
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.